Early treatment with interferon beta-1a may delay MS onset

Washington, DC-Early treatment of patients at high risk for developing multiple sclerosis (MS), i.e., those with optic neuritis, may be beneficial. The use of interferon beta-1a in these patients at the first sign of optic neuritis or other neurologic symptoms with silent lesions on magnetic resonance imaging (MRI) may significantly delay the development of MS.